Breast cancer drug everolimus 'biggest advance in years'
Up to 8,000 women a year could benefit from everolimus, say specialists, after a trial indicated it could "stall" advanced cancer for about four months longer than persisting with the same treatment. About 12,000 women die of advanced breast cancer ...
Exciting new breast cancer drug hailed 'the biggest advance in years'
Wonder drug can halt breast cancer
Novartis rolls out breast cancer drug Afinitor in UK